The Ohio State Univ

1. Janssen Research & Development, LLC $573,488 125 payments
2. PolyNovo North America LLC $260,911 182 payments
3. TESARO, Inc. $107,907 14 payments
4. Novo Nordisk AS $79,829 1 payment
5. Siemens Medical Solutions USA, Inc. $76,930 7 payments
6. Novo Nordisk Health Care AG $59,872 1 payment
7. Merck Sharp & Dohme Corporation $22,292 1 payment
8. C. R. Bard, Inc. & Subsidiaries $11,466 1 payment
9. Davol Inc. $5,500 1 payment
10. Organon LLC $5,412 18 payments

1. Cp-003 $260,911 182 payments
2. Phase 3 Multi Center Randomized Double Blind Placebo Controlled Study to Evaluate the Efficacy Safety Pharmacokinetics and Pharmacodynamics of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis $151,915 13 payments
3. A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease $134,030 74 payments
4. A Phase 1 Dose Escalation and Cohort Expansion Study of Tsr-042, An Anti-Pd-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors $107,907 14 payments
5. 80202135Iim2001 $60,605 6 payments
6. Improving Mental Health for Adolescents and Young Adults undergoing transition by integrating primary care into sickle cell clinics $59,872 1 payment
7. Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia A Multi Center Randomized Double blind Placebo controlled Study $59,813 6 payments
8. ADVIA Centaur?? Systems Preeclampsia Assays OUS Clinical Trial Specimen Collection Protocol $57,906 3 payments
9. A Phase 3b Multi Center Open label PCI32765 Ibrutinib Long term Extension Study $45,885 9 payments
10. 17000139Blc2002 $36,855 2 payments

1. Patient care $5,412 18 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.